Etiometry Co-Authors Award-Winning PCICS Abstract
News and Press Releases
Receives a Prestigious “Top Abstract” Award at the Pediatric Cardiac Intensive Care Society (PCICS) International Meeting
Miami, December 12, 2016—Etiometry, a pioneering leader in next-generation patient monitoring, received a “Top Abstract” award at the PCICS International Meeting for, “Using a High-Fidelity Physiologic Monitoring System to Evaluate a Clinical Protocol for Post-Operative Single Ventricle Congenital Heart Disease.”
The abstract illustrates the tremendous value that high-fidelity data capture brings to the evaluation of the effectiveness of clinical guidelines. It summarizes the results of a joint study between a major Boston pediatric hospital and Etiometry that evaluated the use of the FDA-cleared Etiometry T3 Visualization & Data Aggregation Software to track and record a patient’s physiological state for the purpose of assessing compliance to a clinical protocol as it relates to outcomes.
According to Etiometry COO Evan Butler, “This work demonstrates that the high-frequency, high-fidelity data capture in our T3 Software allows for novel analysis of clinical protocols. It shows how the Etiometry Platform provides unique insight into the effect of guidelines on clinical practice by capturing objective and clear evidence of how patient management is affected by introducing a new standard of care.”
The lead author was Dr. Michael Goldsmith, a pediatric cardiology Fellow at Boston Children’s Hospital, and it was co-authored by Boston Children’s Hospital Pediatric Cardiac Intensivists Dr. Joshua Salvin and Dr. John Kheir and Etiometry’s COO Evan Butler and CTO Dimitar Baronov, PhD.About PCICS
The Pediatric Cardiac Intensive Care Society (PCICS) promotes excellence in pediatric cardiac care medicine. For more information, visit www.pcics.org.About Etiometry
Etiometry Inc. is the leader in clinical decision-support software for the intensive care environment. Our technologies provide valuable clinical insight and analysis to support early recognition of subtle changes in patient condition to avoid complications and speed recovery. Etiometry is committed to improving patient outcomes, increasing clinical efficiency, and lowering costs of care through the more effective use of all available data.
For more information, visit www.etiometry.com.
We’d love to hear from you
Whether you’re curious about how Etiometry can help support your team, the platform’s latest outcomes data or a demo – we’re ready to answer your questions.
Contact UsRelated
HIMSS TV: Etiometry on AI’s role in clinical decision support
In this HIMSS TV interview, Etiometry CEO Shane Cooke dives into the transformative role of AI in clinical decision support—not as a replacement for clinicians, but as a powerful tool to enhance their expertise. Watch the full interview to see how he breaks down how predictive analytics can detect patient deterioration earlier, why AI-driven insights […]
Etiometry Achieves 10th FDA Clearance for Critical Care Platform
FDA Clearance Solidifies Etiometry’s Regulatory Leadership and Cybersecurity Excellence THURSDAY, FEB. 27, 2025- Boston, MA- As cybersecurity threats in healthcare continue to rise, and with the U.S. Food and Drug Administration (FDA) implementing stricter guidelines for cybersecurity compliance, Etiometry, the leader in clinical decision support software for high-acuity units, has received its 10th FDA clearance. This […]
Etiometry Closes the Gap in ARDS/PARDS Detection
In the winter issue of Respiratory Therapy, Jo’el Barr, Clinical Development Specialist at Etiometry, shares insights on the deployment of our PARDS pathway in two top U.S. children’s hospitals. The article highlights how Etiometry’s technology is empowering clinicians to recognize and manage Pediatric ARDS more effectively, driving better outcomes for critically ill children. Read the […]